Multiple sclerosis (MS) is an autoimmune disease that afflicts an approximate 2.5 million patients world-wide, giving rise to multiple issues regarding quality of life and the potential for disability. Up to 15,000 people are newly diagnosed with MS every year in the US, while another 45,000 experience a clinical precursor with similar symptoms. Di (Read more...)